Peter Devilee

Peter Devilee

Universiteit Leiden

H-index: 121

Europe-Netherlands

About Peter Devilee

Peter Devilee, With an exceptional h-index of 121 and a recent h-index of 64 (since 2020), a distinguished researcher at Universiteit Leiden, specializes in the field of cancer genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants

Associations of a breast cancer polygenic risk score with tumor characteristics and survival

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk (vol 55, pg 1435, 2023)

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

Peter Devilee Information

University

Position

Leiden University Medical Center

Citations(all)

72896

Citations(since 2020)

19553

Cited By

61068

hIndex(all)

121

hIndex(since 2020)

64

i10Index(all)

369

i10Index(since 2020)

229

Email

University Profile Page

Google Scholar

Peter Devilee Skills & Research Interests

cancer genetics

Top articles of Peter Devilee

Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction

The Breast

2024/2/1

Corinna Ernst
Corinna Ernst

H-Index: 12

Peter Devilee
Peter Devilee

H-Index: 61

Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants

Clinical Chemistry

2024/1

Mar Infante
Mar Infante

H-Index: 11

Peter Devilee
Peter Devilee

H-Index: 61

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk (vol 55, pg 1435, 2023)

2023/11/1

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Journal of medical genetics

2023/4/1

Andrew Lee
Andrew Lee

H-Index: 2

Peter Devilee
Peter Devilee

H-Index: 61

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Cancers

2023/6/23

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

nature genetics

2023/11

Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls

Frontiers in Genetics

2023/9/18

LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation

The EMBO journal

2023/5/15

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

Genome medicine

2023/1/26

SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma

Journal of Medical Genetics

2023/1/1

Peter Devilee
Peter Devilee

H-Index: 61

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

NPJ Breast Cancer

2023/5/12

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study

European Journal of Human Genetics

2022/9

Peter Devilee
Peter Devilee

H-Index: 61

Risk-adjusted cancer screening and prevention (RiskAP): complementing screening for early disease detection by a learning screening based on risk factors

2022/8/12

See List of Professors in Peter Devilee University(Universiteit Leiden)